Zobrazeno 1 - 10 of 14 pro vyhledávání: '"İVO GÖKMEN"'
1
Akademický článek
Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
Autor: İvo Gökmen, Ebru Taştekin, Nazan Demir, Erkan Özcan, Fahri Akgül, Muhammed Bekir Hacıoğlu, Bülent Erdoğan, Sernaz Topaloğlu, İrfan Çiçin
Publikováno v: Current Issues in Molecular Biology, Vol 45, Iss 10, Pp 7803-7812 (2023)
The aim of our study was to evaluate the incidence of KRAS/NRAS and BRAF mutations, analyze molecular patterns, and investigate associations with clinical parameters of these mutations in CRC KRAS/NRAS and BRAF mutations analyzed by next-generation s
Externí odkaz: https://doaj.org/article/136914033b38496a91f9524dc2a50894
Zobrazit plný text záznamu
2
Akademický článek
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Autor: Cengiz Karacin, Berna Oksuzoglu, Ayşe Demirci, Merve Keskinkılıç, Naziyet Köse Baytemür, Funda Yılmaz, Oğuzhan Selvi, Dilek Erdem, Esin Avşar, Nail Paksoy, Necla Demir, Sema Sezgin Göksu, Sema Türker, Ertuğrul Bayram, Abdüssamet Çelebi, Hatice Yılmaz, Ömer Faruk Kuzu, Seda Kahraman, İvo Gökmen, Abdullah Sakin, Ali Alkan, Erdinç Nayır, Muzaffer Uğraklı, Ömer Acar, İsmail Ertürk, Hacer Demir, Ferit Aslan, Özlem Sönmez, Taner Korkmaz, Özde Melisa Celayir, İbrahim Karadağ, Erkan Kayıkçıoğlu, Teoman Şakalar, İlker Nihat Öktem, Tülay Eren, Enes Erul, Eda Eylemer Mocan, Ziya Kalkan, Nilgün Yıldırım, Yakup Ergün, Baran Akagündüz, Serdar Karakaya, Engin Kut, Fatih Teker, Burçin Çakan Demirel, Kubilay Karaboyun, Elvina Almuradova, Olçun Ümit Ünal, Abdilkerim Oyman, Deniz Işık, Kerem Okutur, Buğra Öztosun, Burcu Belen Gülbağcı, Mehmet Emin Kalender, Elif Şahin, Mustafa Seyyar, Özlem Özdemir, Fatih Selçukbiricik, Metin Kanıtez, İsa Dede, Mahmut Gümüş, Erhan Gökmen, Arzu Yaren, Serkan Menekşe, Senar Ebinç, Sercan Aksoy, Gökşen İnanç İmamoğlu, Mustafa Altınbaş, Bülent Çetin, Başak Oyan Uluç, Özlem Er, Nuri Karadurmuş, Atike Pınar Erdoğan, Mehmet Artaç, Özgür Tanrıverdi, İrfan Çiçin, Mehmet Ali Nahit Şendur, Esin Oktay, İbrahim Vedat Bayoğlu, Semra Paydaş, Adnan Aydıner, Derya Kıvrak Salim, Çağlayan Geredeli, Tuğba Yavuzşen, Mutlu Doğan, İlhan Hacıbekiroğlu
Publikováno v: BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background There is no standard treatment recommended at category 1 level in international guidelines for subsequent therapy after cyclin-dependent kinase 4/6 inhibitor (CDK4/6) based therapy. We aimed to evaluate which subsequent treatment
Externí odkaz: https://doaj.org/article/042edc2981bf4d52a01526b7a7c03f4f
Zobrazit plný text záznamu
3
Akademický článek
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Autor: Cengiz Karacin, Berna Oksuzoglu, Ayşe Demirci, Merve Keskinkılıç, Naziyet Köse Baytemür, Funda Yılmaz, Oğuzhan Selvi, Dilek Erdem, Esin Avşar, Nail Paksoy, Necla Demir, Sema Sezgin Göksu, Sema Türker, Ertuğrul Bayram, Abdüssamet Çelebi, Hatice Yılmaz, Ömer Faruk Kuzu, Seda Kahraman, İvo Gökmen, Abdullah Sakin, Ali Alkan, Erdinç Nayır, Muzafer Uğraklı, Ömer Acar, İsmail Ertürk, Hacer Demir, Ferit Aslan, Özlem Sönmez, Taner Korkmaz, Özde Melisa Celayir, İbrahim Karadağ, Erkan Kayıkçıoğlu, Teoman Şakalar, İlker Nihat Öktem, Tülay Eren, Enes Erul, Eda Eylemer Mocan, Ziya Kalkan, Nilgün Yıldırım, Yakup Ergün, Baran Akagündüz, Serdar Karakaya, Engin Kut, Fatih Teker, Burçin Çakan Demirel, Kubilay Karaboyun, Elvina Almuradova, Olçun Ümit Ünal, Abdilkerim Oyman, Deniz Işık, Kerem Okutur, Buğra Öztosun, Burcu Belen Gülbağcı, Mehmet Emin Kalender, Elif Şahin, Mustafa Seyyar, Özlem Özdemir, Fatih Selçukbiricik, Metin Kanıtez, İsa Dede, Mahmut Gümüş, Erhan Gökmen, Arzu Yaren, Serkan Menekşe, Senar Ebinç, Sercan Aksoy, Gökşen İnanç İmamoğlu, Mustafa Altınbaş, Bülent Çetin, Başak Oyan Uluç, Özlem Er, Nuri Karadurmuş, Atike Pınar Erdoğan, Mehmet Artaç, Özgür Tanrıverdi, İrfan Çiçin, Mehmet Ali Nahit Şendur, Esin Oktay, İbrahim Vedat Bayoğlu, Semra Paydaş, Adnan Aydıner, Derya Kıvrak Salim, Çağlayan Geredeli, Tuğba Yavuzşen, Mutlu Doğan, İlhan Hacıbekiroğlu
Publikováno v: BMC Cancer, Vol 23, Iss 1, Pp 1-2 (2023)
Externí odkaz: https://doaj.org/article/62814a4471cb45089f6723c0cccc8157
Zobrazit plný text záznamu
5
Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma
Autor: Ahmet Kucukarda, Erkan Ozcan, İvo Gökmen, Sezin Sayın, Muhammet Bekir Hacioglu, Sernaz Uzunoglu, Bulent Erdogan, Irfan Cicin, Ali Gökyer
Publikováno v: Supportive Care in Cancer. 30:2131-2139
Purpose: We aimed to identify the prognostic and predictive values of post-treatment prognostic nutritional index (PNI) and PNI dynamics in nasopharyngeal cancer patients (NPC) in this study.Methods: 107 non-metastatic NPC patients were included. PNI
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23539365598f08eeaf941ab59156a786
https://doi.org/10.1007/s00520-021-06627-6
Zobrazit plný text záznamu
6
Prognostic Factors for Survival in Transverse Colon Cancers
Autor: Osman Kostek, Ahmet Kucukarda, Erkan Ozcan, Irfan Cicin, Sernaz Uzunoglu, Ali Gökyer, Muhammet Bekir Hacioglu, Sezin Sayın, İvo Gökmen, Bulent Erdogan
Publikováno v: Journal of Gastrointestinal Cancer. 53:31-40
Transverse colon cancer (TCC) is a rare condition that accounts for 10% of all colon cancers. TCC was accepted more likely right-sided colon cancers. We aimed to investigate whether TCC differs from other colon tumors by using clinical, pathological,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dc8b732588c82c8f16dfe4dc2b749b2
https://doi.org/10.1007/s12029-021-00675-1
Zobrazit plný text záznamu
7
Comparison of real-life data from patients with NGS panel negative and KRAS mutation positive metastatic lung adenocarcinoma
Autor: Erkan Ozcan, Ahmet Kucukarda, İvo Gökmen, Irfan Cicin, Sezin Sayın, Bulent Erdogan, Osman Kostek, Ebru Tastekin, Sernaz Uzunoglu, Bekir Hacioglu, Ali Gökyer
Publikováno v: Tumori Journal. 108:141-146
Objective: To evaluate clinical and demographic characteristics and the results of cytotoxic treatments of KRASG12C, KRASother, and next-generation sequencing (NGS) panel negative patients. Methods: NGS data of 1264 patients with non-small cell lung
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0e36981692d21f101760f7ba74a91041
https://doi.org/10.1177/0300891621996448
Zobrazit plný text záznamu
10
Recurrent delayed immune-related pneumonitis after immune-checkpoint inhibitor therapy for advanced osteosarcoma
Autor: Ahmet Küçükarda, İvo Gökmen, Erkan Özcan, Pınar Peker, Fahri Akgül, İrfan Çiçin
Publikováno v: Immunotherapy. 14(6)
Introduction: The case of a patient who developed recurrent delayed immune-related pneumonitis (checkpoint inhibitor pneumonitis [CIP]) after immune checkpoint inhibitor (ICI) therapy for advanced osteosarcoma treatment is presented. Case summary: A
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d24cb72c19bb951db5ccb6fe65e42aba
https://pubmed.ncbi.nlm.nih.gov/35152716
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje